The FDA said it may consider approving some flavored e-cigarettes, but will continue rejecting flavored products that appeal to teenagers.

The tool can review medical records and wearable data; the feature will roll out in the United States first. HealthDay News — Microsoft is rolling out a new artificial intelligence (AI) tool designed ...

While vitamin D3 does not improve immediate COVID-19 outcomes or reduce medical visits, it may lower the risk of developing long COVID.

Receiving the COVID-19 vaccine and booster reduces preeclampsia risk by nearly 60% among pregnant patients with preexisting morbidities.

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification.

Children of mothers with pregestational or gestational diabetes face increased risk of delayed attainment of early developmental milestones.

Patients with autoimmune thyroiditis who use semaglutide to manage their T2D have fewer TED-related diagnoses at 5 years.

The SMART2 model for estimating recurrent CV risk is well-calibrated overall but slightly underestimates risk in patients with low SES.

Federal regulators have warned the maker of Ozempic and Wegovy that it failed to report possible drug side effects to the government.

GLP-1RAs are associated with greater annualized total hip bone loss in patients without diabetes, driven primarily by weight loss.

The guidelines prioritize earlier lifestyle interventions for the prevention of atherosclerotic cardiovascular disease.

GLP-1 receptor agonist therapy for type 2 diabetes or obesity is associated with a significantly lower risk of developing colon cancer.